Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/6/16 → 07/12/19 |
Funding
- Otsuka Pharmaceutical Development and Commercialization Inc: $7,250.00
Phase 3b Multicenter, Extension Follow-Up Trial to Evaluate the Long-Term Safety of Children and Adolescent Subjects With Euvolemic or Hypervolemic Hyponatremia Who Have Previously Participated in a Trial of Titrated Oral SAMSCA (Tolvaptan)
- Woroniecki, Robert (PI)
- Supe-Markovina, Katarina (CoPI)
Project: Research